Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

19.6K
The microscopic-observation drug-susceptibility (MODS) assay is a low-cost, low-tech tool for high-performance detection of tuberculosis (TB) and multidrug-resistant tuberculosis (MDRTB). This video describes the MODS liquid media culture...
19.6K
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

9.9K
Infections caused by multidrug-resistant (MDR) bacterial strains have emerged as a serious threat to public health, necessitating the development of alternative therapeutics. We present a protocol to evaluate the effectiveness of antimicrobial blue light (aBL) therapy for MDR Acinetobacter baumannii infections in mouse burns by using bioluminescence...
9.9K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

13.2K
An amplification microarray combines asymmetric PCR amplification and microarray hybridization into a single chamber, which significantly streamlines microarray workflow for the end user. Simplifying microarray workflow is a necessary first step for creating microarray-based diagnostics that can be routinely used in lower-resource...
13.2K
Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein10:43

Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein

22.7K
In this protocol we demonstrate the expression, solubilization, and purification of a recombinantly expressed membrane protein, MexB, as a soluble protein detergent complex. MexB is a multidrug resistance membrane transporter from the opportunistic bacterial pathogen Pseudomonas aeruginosa.
22.7K
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

7.8K
We describe the optical imaging of mice infected with Mycobacterium tuberculosis (M. tuberculosis) using reporter enzyme fluorescence (REF). This protocol facilitates the sensitive and specific detection of M. tuberculosis in pre-clinical animal models for pathogenesis, therapeutics and vaccine...
7.8K
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions12:17

An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions

12.4K
Here we describe a rapid equilibrium dialysis (RED) method to measure drug binding to caseum from pulmonary tuberculosis lesions and cavities. The protocol is also used with a foamy macrophage-derived matrix that is an effective surrogate to...
12.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Pathogens and global health·2017
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

Finding New Ways to Combat Multidrug-Resistant Tuberculosis.

Majid Faridgohar1,2

  • 1Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.

Microbial Drug Resistance (Larchmont, N.Y.)
|September 14, 2019
PubMed
Summary
This summary is machine-generated.

Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health threat. Understanding resistance mechanisms and host interactions is key to developing new diagnostic and treatment strategies for MDR-TB.

Keywords:
Mycobacterium tuberculosisdiagnosisimmune systemmulti-drug resistancetargetingtreatment

More Related Videos

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.9K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.2K

Related Experiment Videos

Last Updated: Jan 19, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.9K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.2K

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a critical global health challenge, with multidrug-resistant tuberculosis (MDR-TB) causing substantial mortality.
  • The emergence and spread of MDR-TB necessitate novel approaches for diagnosis and treatment.
  • Understanding the complex interplay between Mycobacterium tuberculosis (Mtb) and the host immune system is crucial for disease control.

Purpose of the Study:

  • To review current knowledge on MDR-TB, including risk factors, disease progression, and resistance mechanisms.
  • To explore the interaction between Mtb and the host immune system.
  • To identify potential future diagnostic and therapeutic targets for MDR-TB.

Main Methods:

  • Literature review of risk factors, progression patterns, and resistance mechanisms in MDR-TB.
  • Analysis of Mtb-host immune interactions.
  • Examination of potential drug targets and diagnostic strategies.

Main Results:

  • Mutations in Mtb are central to the development of drug resistance.
  • Identifying specific mutations can guide personalized anti-TB drug selection and treatment.
  • Targeting Mtb components and enzymes offers pathways for novel therapies.

Conclusions:

  • Effective management of MDR-TB requires a deep understanding of resistance mechanisms and host-pathogen dynamics.
  • Future strategies may involve targeting specific Mtb vulnerabilities and utilizing genetic information for tailored treatments.
  • Accelerated diagnosis and treatment are vital to improve patient outcomes and curb the spread of resistant TB strains.